Kaiku Health raises €4.4 million series A financing to accelerate its digital therapeutics pipeline led by Debiopharm and Tesi
Challenge Qualité de vie du patient 2018 : l’appel à projets est ouvert !
GenePOC launches its revogene™ instrument and GBS LB test in Canada
Debiopharm's vision of healthcare is not limited to making new medicines available. We strongly believe that you can be an actor in your own medical care. Your safety is our top priority.MORE ABOUT CLINICAL TRIALS
April 20, 2018
WATCH ALL EVENTS
© 2018 Debiopharm Group™